Position in ABT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$237,351,067
-$23,711,022 QoQ
Shares Held
2,615,727
+2.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#71
of 2,959 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $929,227,583 across 6 Medical Devices names. ABT ranks #2 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
1,156,684 | $364,170,390 | |
| 2 | ABT |
Abbott Laboratories
This page
|
2,615,727 | $237,351,067 | |
| 3 | BSX |
Boston Scientific Corp
|
4,556,876 | $194,487,467 | |
| 4 | MDT |
Medtronic plc
|
1,683,531 | $131,702,630 | |
| 5 | DXCM |
Dexcom Inc
|
18,724 | $1,261,061 | |
| 6 | SNN |
Smith & Nephew PLC
|
8,850 | $254,968 |
All Filings in ABT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,351,067 | 2,615,727 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $261,062,089 | 2,542,730 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $297,403,754 | 2,373,723 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,589,500 | 198,518 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,801,068 | 322,043 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $51,258,215 | 386,417 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,336,204 | 250,519 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,186,883 | 264,774 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,781,984 | 161,505 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,501,540 | 74,798 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,272,530 | 75,157 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,982,400 | 72,095 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,207,922 | 130,324 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,178,077 | 130,141 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,830,905 | 125,976 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $12,185,954 | 125,940 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,777,797 | 126,809 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,303,474 | 129,296 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,041,911 | 99,772 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $6,547,355 | 55,425 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,076,885 | 17,915 | Shares | Sole | 2021-08-20 | |
| 2021-03-31 | $264,620,381 | 2,208,114 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $174,946,625 | 1,597,832 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $195,288,034 | 1,794,432 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,125,869 | 12,314 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $20,019,230 | 253,697 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||